Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?


EKER S. S. , Yavasci E. O. , CANGÜR Ş., KIRLI S., Sarandol E.

ACTA NEUROPSYCHIATRICA, vol.26, no.5, pp.291-297, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1017/neu.2014.13
  • Journal Name: ACTA NEUROPSYCHIATRICA
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.291-297
  • Keywords: comorbidity, depression, psychoneuroimmunology, schizophrenia, NEUROTROPHIC FACTOR LEVELS, INFLAMMATORY RESPONSE SYSTEM, FACTOR SERUM CONCENTRATIONS, MAJOR DEPRESSION, INTERLEUKIN-2 PRODUCTION, ATYPICAL ANTIPSYCHOTICS, SOLUBLE INTERLEUKIN-2, BIPOLAR DISORDER, CSF LEVELS, BRAIN

Abstract

Objective: The aim of the current study is to determine whether serum levels of brain-derived neurotrophic factor (BDNF) and interleukin-2 (IL-2) can be biological indicators for the diagnosis of schizophrenia in patients with depressive symptoms.